English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Lavie Bio announces appointment of Guri Oron as CEOqrcode

Sep. 15, 2022

Favorites Print
Forward
Sep. 15, 2022

Lavie Bio Ltd. ("Lavie Bio"), a subsidiary of Evogene Ltd. ("Evogene") ( Nasdaq: EVGN), (TASE: EVGN), and a leading ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products, announced the appointment of Guri Oron as Chief Executive Officer ("CEO") of Lavie Bio, effective as of September 18, 2022.

Mr. Oron is a veteran executive in multi-disciplinary, deep-tech organizations, leading medical device and ag-tech companies from inception to market. He brings over 20 years of extensive experience at various early-stage technology companies both in Israel and internationally, most recently at Viridix Ltd., an ag-tech company focused on precision irrigation. Previously, Mr. Oron was the CEO for 7 years at BlueWind Medical Ltd., an active implantable medical device company and prior to that he served as CEO and co-founder at Cybotech Ltd. and as VP R&D at BrainsGate Ltd. He holds a BSc. in electrical engineering from Tel-Aviv University and is a co-author on numerous patents and patent-pending applications.

Guri Oron, incoming CEO of Lavie Bio, stated, "I am honored to have been given the opportunity to lead Lavie Bio as its CEO. I have been very impressed with Lavie Bio's achievements to date and particularly, its achievement in bringing leading global ag-tech partners, namely Corteva and ICL Group, to share in Lavie Bio's vision.  It is very exciting to be joining Lavie Bio at this time, and to lead further progress on realizing the company's vision of improving global food quality, sustainability, and agricultural productivity."

Ofer Haviv, Lavie Bio chairperson & Evogene's President and CEO, added, "We are delighted to welcome Guri Oron to the Evogene Group, to assume the leadership position as CEO of Lavie Bio. Guri has a proven track-record of building and leading early-stage companies and advancing their products and strengthening their business development. I am confident that he is the right person to successfully lead Lavie Bio to its next phase of growth, as we scale up the manufacturing capacity of our bio-stimulant, Thrivus™, advance our bio-pesticide pipeline, and extend the scope of our collaborations with Corteva and ICL Group."   


image.png

Source: Lavie Bio
Click to bookmark and build your agrochemical knowledge base
Print
Forward

0/1200

More from AgroNewsChange

Hot Topic Change

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

Subscribe to daily email alerts of AgroNews.